Text Size

A A A

Search


 

Home | Clinical Trials

FDA Approved Drugs » 1998
Medical Areas: Neurology | Family Medicine

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names

Maxalt

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Merck
Approval Status: Approved June 1998
Treatment Area: Migraine Headaches

General Information

Maxalt has been approved for the acute treatment of migraine headaches. Maxalt is the first and only migraine drug available not only in conventional tablets, but also in a fast-dissolving tablet formulation (disintegrated on the tongue, no water needed).

Clinical Results

In clinical studies it was found that approximately 70% of patients who took Maxalt 10mg reported pain relief at two hours, while 60% of patients who took the 5mg dose reported pain relief at two hours as well. Both formulations will be made available in 10mg and 5mg strengths.


 Back to Top | Printer Friendly Version

Get Involved

Stroke and You

Our Mission Statement

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org